• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[2-¹⁴C]丙硫氧嘧啶在大鼠甲状腺中的氧化代谢产物。

Oxidative metabolites of [2-14C]propylthiouracil in rat thyroid.

作者信息

Lindsay R H, Kelly K, Hill J B

出版信息

Endocrinology. 1979 Jun;104(6):1686-97. doi: 10.1210/endo-104-6-1686.

DOI:10.1210/endo-104-6-1686
PMID:221188
Abstract

The identities and relative amounts of the major metabolites in rat thyroids 6 h after the administration of [14C]propylthiouracil ([14C]PTU) have been investigated. Rat thyroid extracts were chromatographed on columns of Bio-Gel P-2 and DEAE-Sephadex and in various thin layer chromatography systems. The extracts contained protein-bound PTU metabolites; an unknown peak 3; peak 1, which was chromatographically similar to PTU--SO2H; peak 2, which was similar to PTU--SO3H; PTU; and small amounts of 6-n-propyluracil (PU). The major metabolites were isolated and purified by column chromatograpy. On the basis of chromatographic properties identical to cochromatographed standards in seven different systems and the products formed after treatment with various reagents, peak 1 was identified as PTU-SO2H and peak 2 as PTU--SO3H. Peak 3 was seen only on Bio-Gel P-2 columns, was very unstable, and was not similar to any known PTU standard. The properties of this compound suggest that it may be a thiolsulfonic ester (formula:see text), but the data are insufficient for positive identification. Approximately 85% of the radioactivity in the protein peak was bound to thyroglobulin. HCl converted 86.5% of the protein-bound radioactivity to PU, and H2S converted 91% to PTU, indicating that an oxidized S was involved in the linkage to protein. Dithiothreitol released 23.6% of the protein-bound radioactivity as PTU, and mercaptoethanol released 32.5%, indicating that 25-35% of the PTU is bound in disulfide linkage. Approximately 50% of the radioactivity released by mercaptoethanol was S-ethanol PTU, which suggests a PTU-protein bond similar to a thiolsulfonic ester. Quantitation of the metabolites revealed that protein-bound metabolites accounted for 21-29% of the total radioactivity, unknown peak 3 accounted for 7.1%, PTU--SO2H for 48-50%, PTU--SO3H for 8-10%, and PTU for 10.7-16.5%. Only traces of PU were observed. The data demonstrate that PTU--SO2H is the major PTU metabolite in rat thyroid and must be the compound X observed by other investigators and that all metabolites identified are oxidative products of PTU. These findings support the earlier conclusion of Taurog and Riesco that protein binding of PTU occurs as a consequence of oxidation.

摘要

在给予[14C]丙硫氧嘧啶([14C]PTU)6小时后,对大鼠甲状腺中主要代谢产物的种类和相对含量进行了研究。大鼠甲状腺提取物在Bio - Gel P - 2和DEAE - Sephadex柱上以及各种薄层色谱系统中进行色谱分析。提取物中含有与蛋白质结合的PTU代谢产物;未知峰3;峰1,其色谱行为与PTU - SO2H相似;峰2,与PTU - SO3H相似;PTU;以及少量的6 - 正丙基尿嘧啶(PU)。主要代谢产物通过柱色谱法进行分离和纯化。基于在七种不同系统中与共色谱标准品相同的色谱性质以及用各种试剂处理后形成的产物,峰1被鉴定为PTU - SO2H,峰2为PTU - SO3H。峰3仅在Bio - Gel P - 2柱上出现,非常不稳定,且与任何已知的PTU标准品都不相似。该化合物的性质表明它可能是一种硫代磺酸酯(分子式:见正文),但数据不足以进行明确鉴定。蛋白质峰中约85%的放射性与甲状腺球蛋白结合。HCl将86.5%与蛋白质结合的放射性转化为PU,H2S将91%转化为PTU,表明氧化态的S参与了与蛋白质的连接。二硫苏糖醇释放出23.6%与蛋白质结合的放射性作为PTU,巯基乙醇释放出32.5%,表明25 - 35%的PTU以二硫键结合。巯基乙醇释放的放射性中约50%是S - 乙醇PTU,这表明PTU与蛋白质的键类似于硫代磺酸酯。代谢产物的定量分析表明,与蛋白质结合的代谢产物占总放射性的21 - 29%,未知峰3占7.1%,PTU - SO2H占48 - 50%,PTU - SO3H占8 - 10%,PTU占10.7 - 16.5%。仅观察到痕量的PU。数据表明PTU - SO2H是大鼠甲状腺中主要的PTU代谢产物,必定是其他研究者观察到的化合物X,并且鉴定出的所有代谢产物都是PTU的氧化产物。这些发现支持了Taurog和Riesco早期的结论,即PTU与蛋白质的结合是氧化的结果。

相似文献

1
Oxidative metabolites of [2-14C]propylthiouracil in rat thyroid.[2-¹⁴C]丙硫氧嘧啶在大鼠甲状腺中的氧化代谢产物。
Endocrinology. 1979 Jun;104(6):1686-97. doi: 10.1210/endo-104-6-1686.
2
Metabolism of 35S- and 14C-labeled propylthiouracil in a model in vitro system containing thyroid peroxidase.在含有甲状腺过氧化物酶的体外模型系统中,35S和14C标记的丙硫氧嘧啶的代谢
Endocrinology. 1989 Jun;124(6):3030-7. doi: 10.1210/endo-124-6-3030.
3
A reexamination of the proposed inactivation of thyroid peroxidase in the rat thyroid by propylthiouracil.对丙硫氧嘧啶使大鼠甲状腺中甲状腺过氧化物酶失活的提议进行的重新审视。
Endocrinology. 1989 Jun;124(6):3038-42. doi: 10.1210/endo-124-6-3038.
4
Propylthiouracil and methimazole display contrasting pathways of peripheral metabolism in both rat and human.丙硫氧嘧啶和甲巯咪唑在大鼠和人类体内均呈现出不同的外周代谢途径。
Endocrinology. 1988 Feb;122(2):592-601. doi: 10.1210/endo-122-2-592.
5
Binding of the 35-s of 35-s-propylthiouracil by follicular thyroglobulin in vivo and in vitro.
Acta Endocrinol (Copenh). 1975 Jun;79(2):248-58. doi: 10.1530/acta.0.0790248.
6
Mechanism of action of thioureylene antithyroid drugs: factors affecting intrathyroidal metabolism of propylthiouracil and methimazole in rats.硫脲类抗甲状腺药物的作用机制:影响大鼠甲状腺内丙硫氧嘧啶和甲巯咪唑代谢的因素
Endocrinology. 1978 Dec;103(6):2187-97. doi: 10.1210/endo-103-6-2187.
7
Oxidation of propylthiouracil to reactive metabolites by activated neutrophils. Implications for agranulocytosis.活化中性粒细胞将丙硫氧嘧啶氧化为活性代谢产物。对粒细胞缺乏症的影响。
Drug Metab Dispos. 1991 Mar-Apr;19(2):354-9.
8
Effect of frequency of administration on the accumulation and metabolism of (35S) propylthiouracil by the rat thyroid.给药频率对大鼠甲状腺对(35S)丙硫氧嘧啶的蓄积和代谢的影响。
Endocrinology. 1975 May;96(5):1324-8. doi: 10.1210/endo-96-5-1324.
9
Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.硫脲类抗甲状腺药物在大鼠体内的作用机制:丙硫氧嘧啶可能使甲状腺过氧化物酶失活。
Endocrinology. 1983 Jul;113(1):362-70. doi: 10.1210/endo-113-1-362.
10
Lack of effect of propylthiouracil and methylmercaptoimidazole on thyroglobulin biosynthesis.
Proc Soc Exp Biol Med. 1990 May;194(1):48-53. doi: 10.3181/00379727-194-43053.

引用本文的文献

1
The thioamides methimazole and thiourea inhibit growth of M. avium Subspecies paratuberculosis in culture.硫酰胺甲巯咪唑和硫脲可抑制培养中的牛分枝杆菌亚种副结核分支杆菌的生长。
PLoS One. 2010 Jun 14;5(6):e11099. doi: 10.1371/journal.pone.0011099.
2
Pharmacokinetics of antithyroid drugs.
Klin Wochenschr. 1982 Jun 1;60(11):531-9. doi: 10.1007/BF01724208.
3
Clinical pharmacokinetics of antithyroid drugs.抗甲状腺药物的临床药代动力学
Clin Pharmacokinet. 1981 Nov-Dec;6(6):401-28. doi: 10.2165/00003088-198106060-00001.